| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_916075766043ce900399a4c2eee9f054 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-42 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D303-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D303-14 |
| filingDate |
2016-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e63b80b4514819f59256b56310d65429 |
| publicationDate |
2018-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2018086727-A9 |
| titleOfInvention |
NEUROACTIVE SUBSTITUTED CYCLOPENT[a]ANTHRACENES AS MODULATORS FOR GABA TYPE-A RECEPTORS |
| abstract |
The present disclosure is generally directed to neuroactive substituted cyclopent[a]anthracenes as referenced herein, and pharmaceutically acceptable salts thereof, for use as, for example, an anesthetic, and/or in the treatment of disorders relating to GABA function and activity. The present disclosure is further directed to pharmaceutical compositions comprising such compounds. |
| priorityDate |
2013-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |